Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CRDL stock hub

Cardiol Therapeutics Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CRDLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

147.1M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CRDL

In the news

Latest news · CRDL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-158.8

P25 -105.6P50 -46.5P75 -3.1

ROIC-100

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CRDL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

176

Groups with data

Currency

CAD

Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001702123
Company name	Cardiol Therapeutics Inc.
Country	Canada
Country code	US
Cusip	14161Y200
Employees	18
Employees Change	12%
Employees Change Percent	200
Enterprise value	$131.5M
Exchange	NASDAQ
Financial currency	CAD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA14161Y2006
Last refreshed	2026-05-10
Market cap	$147.1M
Market cap category	Micro-Cap
Price	$1.32
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	CRDL
Website	https://www.cardiolrx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.77%
FCF yield	-11.87%
P/B ratio	11.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-24.7M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Profit Per Employee	$-1.4M
ROA	-77.31
Roa5y	-53.9
ROCE	-191
ROE	-158.8
Roe5y	-97.2
ROIC	-100

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	22.81%
Cagr3y	29.34%
Cagr5y	-13.21%
EPS Growth Quarters	2
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$17.2M
Cash	$15.6M
Current Assets	$17.2M
Current Liabilities	$4.1M
Debt	$91,548
Debt Equity	$0.01
Equity	$13M
Liabilities	$4.2M
Long Term Assets	$35,098
Long Term Liabilities	$51,301
Net Cash	$15.5M
Net Cash By Market Cap	$10.56
Net Cash Growth	-30.01%
Net Debt Equity	$-1.19
Tangible Book Value	$13M
Tangible Book Value Per Share	$0.13
WACC	6.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.16
Net Working Capital	$-2.6M
Quick ratio	3.83
Working Capital	$13M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-21.55%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	22.79%
200-day SMA	1.12
3Y total return	116.39%
50-day SMA	1.24
50-day SMA vs 200-day SMA	50over200
5Y total return	-50.75%
All Time High	10
All Time High Change	-86.8%
All Time High Date	2019-02-25
All Time Low	0.45
All Time Low Change	193.33%
All Time Low Date	2023-04-05
ATR	0.09
Beta	0.43
Ch YTD	38.39
High	1.34
High52	1.71
High52 Date	2026-04-22
High52ch	-22.81%
Low	1.28
Low52	0.88
Low52 Date	2025-12-01
Low52ch	50%
Ma50ch	6.71%
Premarket Change Percent	0.77
Premarket Price	$1.31
Premarket Volume	21,382
Price vs 200-day SMA	18.17%
RSI	48.71
RSI Monthly	50.43
RSI Weekly	57.67
Sharpe ratio	0.58x
Sortino ratio	1.01
Total Return	-21.55%
Tr YTD	38.39
Tr1m	-5.71%
Tr1w	-3.65%
Tr3m	32.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.07
Operating Income	$-25M
Price target	$8.5
Price Target Change	$544

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	96,489,056%
Float Percent	86.25%
Net Borrowing	-40,507.7
Shares Insiders	3.05%
Shares Institutions	7.63%
Shares Out	111,872,084
Shares Qo Q	15.6%
Shares Yo Y	21.55%
Short Float	2.05%
Short Ratio	1.98
Short Shares	1.77

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-25.3M
Average Volume	675,008.7x
Bv Per Share	0.13
CAPEX	$-17,857
Ch1m	-5.71
Ch1w	-3.65
Ch1y	22.79
Ch3m	32.69
Ch3y	116.4
Ch5y	-50.75
Ch6m	29.41
Change	1.54%
Change From Open	-0.75
Close	1.3
Days Gap	2.31
Depreciation Amortization	27,796.3
Dollar Volume	763,832.5
Earnings Date	2026-05-14
Earnings Time	amc
EBIT	$-25M
EBITDA	$-25M
EPS	$-0.28
F Score	1
FCF	$-17.5M
FCF EV Yield	-13.28x
FCF Per Share	$-0.16
Financing CF	11,333,676
Fiscal Year End	December
Founded	2,017
Investing CF	-17,857
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2024-04-01
Ma150	1.1
Ma150ch	20%
Ma20	1.4
Ma20ch	-5.51%
Net CF	-6,683,109
Next Earnings Date	2026-05-22
Open	1.33
Optionable	Yes
Position In Range	72.73
Post Close	1.32
Postmarket Change Percent	-0.76
Postmarket Price	$1.31
Ppne	86,385.3
Pre Close	1.3
Price Date	2026-05-08
Ptbv Ratio	11.28
Relative Volume	0.86x
Share Based Comp	7,804,505
Tr6m	29.41%
Volume	578,661

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CRDL pay a dividend?

Capital-return profile for this ticker.

Performance

CRDL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CRDL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.6%

Float: +86.2% of shares outstanding

Insider ownership

+3.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CRDL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.7

Neutral momentum band

Price vs 200-day MA

+18.2%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

0.58

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CRDL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CRDL stock rating?

Cardiol Therapeutics Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CRDL analysis?

The full report lives at /stocks/CRDL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CRDL?

The latest report frames CRDL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CRDL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.